New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Harvard Bioscience, Inc.
HBIO
Shape
US Flag

NASDAQ

61M

Medical - Instruments & Supplies

Next Earning date - 06 Mar 2025

61M

Medical - Instruments & Supplies

Next Earning date - 06 Mar 2025

1.41USD

Shape-0.03 ( -2.08%)
sun-fogPre-market 1.41$arrow-right-up0.00 (0.00%)
Market Closed (as of Feb 10, 22:22 EDT)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

1%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

71%

Quote Panel

Shape
Updated February 11, 2025
1W -15.06 % 1M -28.79 % 3M -38.16 % 1Y -70.69 %

Key Metrics

Shape
  • Market Cap

    61.50M


  • Shares Outstanding

    43.62M


  • Share in Float

    40.16M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    1.41


  • Average Volume

    228677.3


  • Beta

    1.313


  • Range

    1.38-4.93


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.harvardbioscience.com


  • Sector

    Healthcare


Fundamentals

Shape

141.00x

P/E Ratio

0.63x

P/S Ratio

0.94x

P/B Ratio

0.7

Debt/Equity

-14.6%

Net Margin

$-0.3

EPS

How HBIO compares to sector?

P/E Ratio

Relative Strength

Shape

HBIO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$98M

Shape345%

2025-Revenue

$0.13

Shape214%

2025-EPS

$6M

Shape406%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Benchmark

upgrade

Previous: Not converted

2023-03-10

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-50%

0.04
vs 0.08

Q1.23

arrow
arrow

+50%

0.06
vs 0.04

Q2.23

arrow
arrow

-20%

0.04
vs 0.05

Q3.23

arrow
arrow

+200%

0.01
vs -0.01

Q4.23

arrow
arrow

N/A

0.04
vs 0.04

Q1.24

arrow
arrow

-67%

0.02
vs 0.06

Q2.24

arrow
arrow

N/A

-0.03
vs 0.04

Q3.24

arrow
arrow

N/A

-0.02
vs 0.01

Q4.24

arrow
arrow

+25%

0.05
vs 0.04

Q1.25

arrow
arrow

-25%

0.01
vs 0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-14%

28.4M  vs 33.1M

Q1.23

arrow
arrow

+4%

30M  vs 28.8M

Q2.23

arrow
arrow

-2%

28.8M  vs 29.2M

Q3.23

arrow
arrow

-6%

25.4M  vs 26.9M

Q4.23

arrow
arrow

-1%

28.2M  vs 28.4M

Q1.24

arrow
arrow

-18%

24.5M  vs 30M

Q2.24

arrow
arrow

-20%

23.1M  vs 28.8M

Q3.24

arrow
arrow

-13%

22M  vs 25.4M

Q4.24

arrow
arrow

-14%

24.1M  vs 28.2M

Q1.25

arrow
arrow

-6%

22.9M  vs 24.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-2%

-0.02
vs -0.05

Q1.23

arrow
arrow

+1%

0.01
vs -0.02

Q2.23

arrow
arrow

-1%

-0.01
vs 0.01

Q3.23

arrow
arrow

-2%

-0.02
vs -0.01

Q4.23

arrow
arrow

-2%

-0.02
vs -0.02

Q1.24

arrow
arrow

-7%

-0.07
vs -0.02

Q2.24

arrow
arrow

-4%

-0.04
vs -0.07

Q3.24

arrow
arrow

-7%

-0.07
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

67

67
vs 76

-12%

Q1.23

arrow
arrow

67

67
vs 67

NA

Q2.23

arrow
arrow

103

103
vs 67

54%

Q3.23

arrow
arrow

98

98
vs 103

-5%

Q4.23

arrow
arrow

94

94
vs 98

-4%

Q1.24

arrow
arrow

90

90
vs 94

-4%

Q2.24

arrow
arrow

101

101
vs 90

12%

Q3.24

arrow
arrow

95

95
vs 101

-6%

Earnings Growth

Latest News